We assign a fundamental rating of 2 out of 10 to TLPH. TLPH was compared to 191 industry peers in the Pharmaceuticals industry. The financial health of TLPH is average, but there are quite some concerns on its profitability. TLPH does not seem to be growing, but still is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -40.3% | ||
| ROE | -64.6% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 12540700% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -19.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.83 | ||
| Quick Ratio | -1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.52 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 2 / 10 to TLPH.
ChartMill assigns a valuation rating of 1 / 10 to TALPHERA INC (TLPH). This can be considered as Overvalued.
TALPHERA INC (TLPH) has a profitability rating of 1 / 10.
The financial health rating of TALPHERA INC (TLPH) is 5 / 10.